In addition to promoting bone regeneration and repair , ICA also has many beneficial pharmacological and biological activities , including neuroprotective effects ; protective effects against atherosclerosis ; antitumor effects ; anti-inflammatory and antioxidant effects ; and improved sexual function effects .
1,2 person
5,7 abstract|10,11 substance|13,19 abstract|21,23 abstract|24,26 abstract|29,31 abstract|32,36 abstract|38,42 abstract

) is the main active flavonoid glucoside from herbs of the genus Epimedium ; these herbs are used in traditional Chinese medicine and have long been prescribed for the treatment of bone fractures and osteoporosis as a bone-protecting agent .
1,2 person
9,14 plant|15,17 plant|20,23 abstract|29,34 abstract|29,34 event|35,36 object

Several studies have reported that pretreatment of human mesenchymal stem cells ( MSCs ) with cAMP analogs , adenylate cyclase activators or phosphodiesterase inhibitors can enhance bone formation .
1,2 person
1,3 abstract|13,14 object|27,28 object|27,29 abstract

The combination of BMP2 and these small molecules can promote BMP2-mediated osteoblast differentiation and reduces the risk of its side effects in the treatment of bone diseases .
1,2 person
1,9 abstract|6,9 substance|11,13 object|16,22 abstract|19,22 abstract|23,28 abstract|23,28 event|26,28 abstract

Bone morphogenetic protein 2 ( BMP2 ) is one of the most important growth factors that induce osteoblast differentiation and stimulate bone or cartilage formation .
1,2 person
1,5 abstract|9,16 abstract|18,20 event|24,25 object

Hence , it is necessary to find additional agents or methods for the improvement of BMP2 itself to intensify the osteogenic effects of BMP2 .
1,2 person
3,4 event|11,12 abstract|13,18 abstract|16,18 abstract|20,25 abstract

Several animal and cell studies have shown that treatment with ICA can increase osteogenic differentiation and reduce bone loss in vivo and in vitro .
1,2 person
1,6 abstract|11,12 substance|14,16 abstract|18,20 abstract

However , the therapeutic dose of BMP2 is very expensive , and there are some life-threatening side effects that can occur with larger doses .
1,2 person
7,8 object|15,19 abstract|23,25 abstract

From a clinical perspective , these small molecules that regulate BMP2 activity provide powerful tools for the treatment of osteoporosis and fracture repair .
1,2 person
2,5 abstract|11,12 object|11,13 abstract|14,24 abstract|17,21 abstract|17,24 abstract|22,24 abstract|22,24 event

Therefore , ICA is a promising candidate as an alternative for BMP2 or as a promoter for enhancing the therapeutic effects of BMP2 .
1,2 person
3,4 abstract|12,13 object|19,24 abstract|23,24 object

Bone disorders , especially osteoporosis , are becoming increasingly prevalent as the aging population grows , and bone fractures also occur frequently .
1,2 person
1,3 abstract|12,15 abstract|18,19 object

This combination will reduce the risk of side effects from BMP2 in the treatment of bone diseases such as osteoporosis .
1,2 person
1,3 abstract|5,10 abstract|8,10 abstract|13,21 abstract

We concluded that the combination of ICA and BMP2 could promote BMP2-mediated osteoblast differentiation in a dose-dependent manner .
1,2 person
1,2 person|4,10 abstract|7,8 substance|9,10 object|16,19 abstract

The extremely low cost of ICA and its strong bone regenerative effects indicate its potential in clinical applications .
1,2 person
6,7 object|6,7 substance|8,9 substance|8,13 abstract|10,11 object|14,15 substance|14,19 abstract|17,19 abstract

Osteoporosis contributes significantly to global healthcare costs , and the treatment of osteoporosis remains a great challenge .
1,2 person
1,2 abstract|5,8 abstract|10,14 abstract|10,14 event|13,14 object|15,18 abstract

Thus , new bone anabolic drugs need to be developed for the prevention and treatment of osteoporosis .
1,2 person
12,18 abstract

In the present study , we combined ICA and BMP2 to promote osteogenesis for the first time .
1,2 person
2,5 abstract|6,7 person|8,9 substance|10,11 object|13,14 abstract

We aimed to determine whether ICA could enhance the osteogenic induction of BMP2 in C2C12 cells .
1,2 person
1,2 person|9,17 abstract

Several previous studies have reported that PTH affects osteoblastic cells by activating the cAMP/PKA/CREB axis .
1,2 person
1,4 abstract|1,4 event|9,11 object|13,16 abstract

We also found that ICA stimulates BMP2-mediated osteogenesis by activating the cAMP/PKA/CREB signaling pathway .
1,2 person
1,2 person|7,9 object|11,15 abstract

The cAMP/PKA/CREB axis is a vital pathway that regulates osteogenic differentiation and mineralization .
1,2 person
1,4 abstract|5,8 abstract|10,14 abstract

BMP2 has been widely used in the clinic to promote bone formation .
1,2 person
7,9 abstract

Icariin ( ICA ) ( the chemical structure is shown in
1,2 person
3,4 abstract|6,9 abstract

1 .
1,2 person


Figure 1
1,2 person
1,3 object

Introduction
1,2 person
1,2 abstract
